SH Pharma receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Shanghai Pharmaceuticals Holding Co Ltd (2607)
The Shanghai Pharma Holding share price today is 11.76, view HK 2607 stock exchange data. Track the latest Shanghai Pharma Holding share price with real-time updates on 2607 stock performance including market cap, day range, 52-week range and dividend yield. Access 2607 charts, earnings dates and analyst estimates to support your investment decisions.
11.76
+0.06(+0.51%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
11.67
12.15
52 wk Range
10.50
13.12
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
11.6712.15
52 wk Range
10.5013.12
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.84%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.84%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
2607 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
13.92
Upside
+18.38%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Valuation implies a strong free cash flow yield
- Shanghai Pharm receives Investment Bank Analyst Rating Update
- Investing.com
Pro - SH Pharma receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- SH Pharma receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Shanghai Pharm receives Investment Bank Analyst Rating Update
- Investing.com
Pro - SH Pharma receives Investment Bank Analyst Rating Update
- Investing.com
Pro - SH Pharma receives Investment Bank Analyst Rating Update
- Investing.com
Pro - SH Pharma receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Analyst Ratings
7 Buy
1 Hold
1 Sell
Ratings:
9 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 13.92
(+18.38% Upside)
Earnings
Latest Release
29-04-2026
EPS / Forecast
0.38 / 0.33
Revenue / Forecast
75.26B / 59.56B
Compare 2607 to Peers and Sector
Metrics to compare | 2607 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship2607PeersSector | |
|---|---|---|---|---|
P/E Ratio | 9.8x | 16.7x | −0.5x | |
PEG Ratio | 0.29 | −0.54 | 0.00 | |
Price/Book | - | 1.3x | 2.6x | |
Price / LTM Sales | 0.2x | 0.8x | 3.2x | |
Upside (Analyst Target) | 25.0% | 24.0% | 48.8% | |
Fair Value Upside | Unlock | 23.4% | 6.9% | Unlock |
Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as invests in equity. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Shanghai Pharma Holding (2607) Share Price Today?
The Shanghai Pharma Holding share price today is 11.76.
What is the current Shanghai Pharma Holding (2607) share price and day range?
As of 01-05-2026, the Shanghai Pharma Holding share price is 11.76, with a previous close of 11.70. The share price has ranged from 11.67 to 12.15 today, while the 52-week range spans from 10.50 to 13.12.
What Is the Shanghai Pharma Holding Market Cap?
As of today, Shanghai Pharma Holding market cap is 65.50B.
Does Shanghai Pharma Holding Pay Dividends? What's The Current Dividend Yield?
The Shanghai Pharma Holding dividend yield is 3.84%.
What Is the Shanghai Pharma Holding (2607) Share Price Target?
The average 12-month share price target for Shanghai Pharma Holding is 13.92, with a high estimate of 15.8 and a low estimate of 10.3. 7 analysts recommend buying, while 1 suggest selling, with an overall rating of Buy and +18.38% Upside potential.
What Is Shanghai Pharma Holding's Earnings Per Share (TTM)?
The Shanghai Pharma Holding EPS (TTM) is 1.56.
When Is the Next Shanghai Pharma Holding Earnings Date?
Shanghai Pharma Holding will release its next earnings report on 27-08-2026.
From a Technical Analysis Perspective, Is 2607 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
What Stock Exchange Does Shanghai Pharma Holding Trade On?
Shanghai Pharma Holding is listed and trades on the Hong Kong Stock Exchange.
What Is the Stock Symbol for Shanghai Pharma Holding?
The stock symbol for Shanghai Pharma Holding is "2607."
How Many Times Has Shanghai Pharma Holding Stock Split?
Shanghai Pharma Holding has split 0 times.
How Many Employees Does Shanghai Pharma Holding Have?
Shanghai Pharma Holding has 49608 employees.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.